IHS Chemical Week

World News and Views :: Top of the News

DSM Reports Steady Growth, Seeks Deal in Pharmaceuticals

2:49 AM MDT | August 2, 2011 | Alex Scott

DSM has reported Ebitda for the second quarter of the year up 2% to €339 million ($482 million) on sales up 7% to €2.3 billion. Strong life sciences results were driven by robust growth in the group’s nutrition and materials businesses. The strong U.S. dollar negatively impacted the group overall, the company says.   The performance of the pharmaceuticals manufacturing business “remains below acceptable levels,” however, Sijbesma says. The pharma business recorded second quarter sales down 9% to €178 million. “We know...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa